33 results
424B5
ICON Operational Financing Unlimited Co
2 May 24
Prospectus supplement for primary offering
10:16am
to pharmaceutical, biotechnology, medical device and government and public health organizations. Our mission is to improve the lives of patients … I-IV projects.
Delivery of our mission and strategy is focused on our four strategic pillars, being (i) Patient Access & Engagement (ii) Career
424B5
ICON Operational Financing Unlimited Co
26 Apr 24
Prospectus supplement for primary offering
9:41am
mission is to improve the lives of patients by accelerating the development of our customers’ drugs and devices through innovative solutions.
We … to ensure we will be considered for all major Phase I-IV projects.
Delivery of our mission and strategy is focused on our four strategic pillars
F-3ASR
Pharmaceutical Research Associates, Inc.
26 Apr 24
Automatic shelf registration (foreign)
8:19am
and public health organizations. Our mission is to improve the lives of patients by accelerating the development of our customers’ drugs and devices
6-K
EX-99.3
ICLR
Icon Plc
12 Jun 23
Notice of Annual General Meeting
8:07am
mission is to improve the lives of patients by accelerating the development of our customers’ drugs and devices through innovative solutions.
We … to ensure we will be considered for all major Phase I-IV projects.
Delivery of our mission and strategy is focused on our four strategic pillars, being (i
6-K
EX-99.3
pniky
17 Jun 22
Notice of Annual General Meeting
9:12am
6-K
EX-99.3
g757vkfa93
16 Jun 21
Notice of Annual General Meeting
4:16pm
425
yp80s1a f9xv8
21 May 21
Business combination disclosure
4:17pm
425
auwgcns0p iltnfgf
11 May 21
Business combination disclosure
5:07pm
424B3
rymjpttsyxvb8c
28 Apr 21
Prospectus supplement
12:00am
F-4/A
ayt5zwaqwf5p63pz
26 Apr 21
Registration of securities (foreign) (amended)
9:11pm
F-4
qd7ebo2yydry2p
31 Mar 21
Registration of securities (foreign)
9:09am
425
h8q954knmr 8hhfo1
24 Feb 21
Business combination disclosure
5:15pm
425
58u52
24 Feb 21
Business combination disclosure
5:08pm
425
x8yj7lkv4k 99
24 Feb 21
Business combination disclosure
5:06pm
6-K
EX-99.3
kb0 u16w9v
9 Jun 20
Current report (foreign)
7:55am
6-K/A
EX-99.1
as3lib2
21 May 19
Current report (foreign) (amended)
3:12pm